Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric Cancer
Clinical trial NCT05914610 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05914610
- Sponsor
- Fujian Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2025-07-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.